Ladiratuzumab
CAS: 1629760-28-6
Ref. TM-T77415
| 1mg | 245.00 € | ||
| 5mg | 500.00 € | ||
| 10mg | 815.00 € | ||
| 25mg | 1,197.00 € | ||
| 50mg | 1,616.00 € |
Estimated delivery in United States, on Friday 29 Nov 2024
Product Information
Name:
Ladiratuzumab
Synonyms:
- hLIV22
Description:
LadiratuzumAb (hLIV22) is a humanized monoclonal antibody targeting LIV-1/ZIP6.LadiratuzumAb is a naked antibody to SGN-LIV1A and is capable of synthesizing an
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Purity:
95% - > 95%
Color/Form:
Liquid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T77415 Ladiratuzumab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
